MaRS Monthly Roundup – March 2024

Published on March 4, 2024

We’re back with another MaRS Monthly — bringing you the latest developments in tech across Canada. Here’s a recap for the month of February!

The post MaRS Monthly Roundup – March 2024 appeared first on MaRS Discovery District.

Continue reading on website
Other news

Innovative Medicines Canada Statement on Proposed Pharmacare Legislation

March 4, 2024
OTTAWA, ON – Innovative Medicines Canada (IMC) is concerned with the federal government’s intent in Bill C-64, An Act respecting pharmacare (Pharmacare Act), to incrementally implement a universal, single-payer pharmacare system in Canada.“Canadians should be concerned about the impact of the proposed pharmacare model on their existing public and private drug coverage,” said David Renwick, Interim

A new chapter for biotech: Confidence returns to the market

March 4, 2024
After a few years characterised by uncertainty, the narrative across the biotech industry is changing. We have seen a steady upswell in optimism among biotech organisations and other stakeholders over the recent months as new activity announcements set the tone for a ‘return to normal’. The Financial Times noted that the US biotech sector is bouncing back, quoting data from Jeffries that shows Jan